Stockhead on MSN7mon
LTP enters deal with Aptar Pharma to develop Spontan nasal spray
LTP says the application for Spontan nasal spray will be filed in the ... in obtaining their combination drug-device product ...
FOX40 News1mon
Nasus Pharma To Present Positive Clinical Results From Recent studies of FMXIN002 (NS002) Intranasal Epinephrine at the 2025 AAAAI Annual Meeting
FMXIN002, also known as NS002, is a powder formulation of epinephrine nasal spray developed by ... FMXIN002 uses APTAR Nasal Unidose Powder device – an intuitive and easy-to-use device with ...